Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RIPK1 | Q13546 | 1/20 | 0.52 |
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.48 |
| ▸ | HTR2A | P28223 | 1/20 | 0.46 |
| ▸ | CSNK1E | P49674 | 1/20 | 0.45 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.44 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | ASAH1 | Q13510 | 1/20 | 0.44 |
| ▸ | ACER2 | Q5QJU3 | 1/20 | 0.44 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.44 |
| ▸ | NAAA | Q02083 | 2/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.43 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.43 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.43 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16167490 | 1.00 | RIPK1 (0.52) | RIPK1TAAR1HTR2ACSNK1ETRPA1 | |
| Benzene SCHEMBL27847455 | 1.00 | RIPK1 (0.52) | RIPK1TAAR1HTR2ACSNK1ETRPA1 | |
| SCHEMBL5961079 | 1.00 | RIPK1 (0.52) | RIPK1TAAR1HTR2ACSNK1ETRPA1 | |
| SCHEMBL3080030 | 1.00 | RIPK1 (0.52) | RIPK1TAAR1HTR2ACSNK1ETRPA1 | |
| SCHEMBL1299997 | 1.00 | RIPK1 (0.52) | RIPK1TAAR1HTR2ACSNK1ETRPA1 | |
| SCHEMBL1412787 | 1.00 | RIPK1 (0.52) | RIPK1TAAR1HTR2ACSNK1ETRPA1 | |
| SCHEMBL1581397 | 1.00 | RIPK1 (0.52) | RIPK1TAAR1HTR2ACSNK1ETRPA1 | |
| SCHEMBL9746665 | 1.00 | RIPK1 (0.52) | RIPK1TAAR1HTR2ACSNK1ETRPA1 | |
| SCHEMBL16167034 | 1.00 | RIPK1 (0.52) | RIPK1TAAR1HTR2ACSNK1ETRPA1 | |
| SCHEMBL8509010 | 1.00 | RIPK1 (0.52) | RIPK1TAAR1HTR2ACSNK1ETRPA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111793152-A | Photoinitiator composition and application thereof | 张程 | 2020-10-20 | — | — | CN | claimed |
| WO-2014031087-A1 | NATURAL SYNERGISTIC FORMULATIONS CONTAINING ANDROGRAPHIS PANICULATA EXTRACTS FOR SUPPORTING THE INHIBITION OF CARTILATE DEGRADATION IN DEGENERATIVE JOINT DISEASE | AGRICULTURAL RESEARCH DEVELPOMENT AGENCY (PUBLIC ORGANIZATION) (TH) | 2014-02-27 | — | — | WO | claimed |
| CN-118931212-A | Liquid rubber modifier/SBS composite modified asphalt and preparation method thereof | 陕西交控科技发展集团股份有限公司 | 2024-11-12 | — | — | CN | disclosed |
| CN-113167695-A | Device for collecting volatile organic compounds | 法国由内政部代表 | 2021-07-23 | — | — | CN | disclosed |
| CN-111793152-A | Photoinitiator composition and application thereof | 张程 | 2020-10-20 | — | — | CN | disclosed |
| CN-106715669-B | Azeotrope-like compositions containing the chloro- 1,3,3,3- tetrafluoropropene of 2- and the chloro- 3,3,3- trifluoro propene of 1- | 中央硝子株式会社 | 2019-05-10 | — | — | CN | disclosed |
| EP-2984055-B1 | PREPARATION OF SURFACTANTS VIA CROSS-METATHESIS | MATERIA INC (US) | 2018-10-17 | — | — | EP | disclosed |
| US-9758445-B2 | Preparation of surfactants via cross-metathesis | MATERIA, INC. (US) | 2017-09-12 | — | — | US | disclosed |
| US-9758445-B2 | Preparation of surfactants via cross-metathesis | MATERIA, INC. (US) | 2017-09-12 | — | — | US | disclosed |
| US-9663459-B2 | Preparation of surfactants via cross-metathesis | MATERIA, INC. (US) | 2017-05-30 | — | — | US | disclosed |
| US-9663459-B2 | Preparation of surfactants via cross-metathesis | MATERIA, INC. (US) | 2017-05-30 | — | — | US | disclosed |
| US-8366907-B2 | Deoxygenation of fatty acids for preparation of hydrocarbons | BATTELLE MEMORIAL INSTITUTE (US) | 2013-02-05 | — | — | US | disclosed |
| US-20130018213-A1 | DEOXYGENATION OF FATTY ACIDS FOR PREPARATION OF HYDROCARBONS | BATTELLE MEMORIAL INSTITUTE | 2013-01-17 | — | — | US | disclosed |
| US-20130008080-A1 | DEOXYGENATION OF FATTY ACIDS FOR PREPARATION OF HYDROCARBONS | BATTELLE MEMORIAL INSTITUTE | 2013-01-10 | — | — | US | disclosed |
| WO-2012018739-A1 | DEOXYGENATION OF FATTY ACIDS FOR PREPARATION OF HYDROCARBONS | BATTELLE MEMORIAL INSTITUTE (US) | 2012-02-09 | — | — | WO | disclosed |
| US-20120029250-A1 | DEOXYGENATION OF FATTY ACIDS FOR PREPARATION OF HYDROCARBONS | BATTELLE MEMORIAL INSTITUTE | 2012-02-02 | — | — | US | disclosed |
| CN-1402698-A | Use of metathesis products of fischer-tropsch products | SASOL TECH PTY LTD (ZA) | 2003-03-12 | — | — | CN | disclosed |
| EP-1198442-A1 | USE OF METATHESIS PRODUCTS OF FISCHER-TROPSCH PROCESS PRODUCTS | Sasol Technology (Proprietary) Limited (ZA) | 2002-04-24 | — | — | EP | disclosed |
| WO-2001002328-A1 | USE OF METATHESIS PRODUCTS OF FISCHER-TROPSCH PROCESS PRODUCTS | SASOL TECHNOLOGY (PTY) LTD. (ZA) | 2001-01-11 | — | — | WO | disclosed |
| WO-2001002512-A1 | USE OF DIMERIZED FISCHER-TROPSCH PROCESS PRODUCTS AND VINYLIDENE DERIVATIVES THEREOF | SASOL TECHNOLOGY (PTY) LTD. (ZA) | 2001-01-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130018213-A1 | DEOXYGENATION OF FATTY ACIDS FOR PREPARATION OF HYDROCARBONS | ELOVL3, FASN, ELOVL5 | RIPK1 4663/4885TAAR1 2528/4885HTR2A 2751/4885 |
| US-20120029250-A1 | DEOXYGENATION OF FATTY ACIDS FOR PREPARATION OF HYDROCARBONS | ELOVL3, FASN, ELOVL5 | RIPK1 4663/4885TAAR1 2528/4885HTR2A 2751/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.